| [1] |
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: a cancer journal for clinicians, 2013, 63(1): 11-30.
|
| [2] |
Sinclair P, Singh A, Riaz AA, et al. An unsolved conundrum: the ideal follow-up strategy after curative surgery for colorectal cancer. Gastrointestinal endoscopy, 2012, 75(5): 1072-1079.
|
| [3] |
Kato K, Hida Y, Miyamoto M, et al. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer, 2002, 94(4): 929-933.
|
| [4] |
Suzuoki M, Miyamoto M, Kato K, et al. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. British journal of cancer, 2002, 87(10): 1140-1144.
|
| [5] |
Cokakli M, Erdal E, Nart D, et al. Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion, BMC cancer, 2009; 9: 65.
|
| [6] |
Zhang ZB, Cai L, Zheng SG, et al. Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery. Pathology oncology research: POR, 2009, 15(3): 495-502.
|
| [7] |
Capozza F, Williams TM, Schubert W, et al. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. The American journal of pathology, 2003, 162(6): 2029-2039.
|
| [8] |
Goetz JG, Lajoie P, Wiseman SM, et al. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer metastasis reviews, 2008, 27(4): 715-735.
|
| [9] |
El-Gendi SM, Mostafa MF, El-Gendi AM. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome. Pathology oncology research : POR, 2012, 18(2): 459-469.
|
| [10] |
Elsheikh SE, Green AR, Rakha EA, et al. Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. British journal of cancer, 2008, 99(2): 327-334.
|
| [11] |
Karam JA, Lotan Y, Roehrborn CG, et al. Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. The Prostate, 2007, 67(6): 614-622.
|
| [12] |
Joo HJ, Oh DK, Kim YS, et al. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int, 2004, 93(3): 291-296.
|
| [13] |
Razani B, Altschuler Y, Zhu L, et al. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry, 2000, 39(45): 13916-13924.
|
| [14] |
Barresi V, Cerasoli S, Tuccari G. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology : official journal of the Japanese Society of Neuropathology, 2008, 28(5): 472-478 .
|
| [15] |
Moon KC, Lee GK, Yoo SH, et al. Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. Anticancer research,2005, 25(6C): 4631-4637.
|
| [16] |
Choi HN, Kim KR, Park HS, et al. Expression of caveolin in hepatocellular carcinoma: association with unpaired artery formation and radiologic findings. The Korean journal of hepatology, 2007, 13(3): 396-408.
|
| [17] |
Zhou H, Jia L, Wang S, et al. Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability. Biochem Biophys Res Commun, 2006, 345(1): 486-494.
|
| [18] |
Zhao X, Liu Y, Ma Q, et al. Caveolin-1 negatively regulates TRAIL-induced apoptosis in human hepatocarcinoma cells. Biochem Biophys Res Commun, 2009, 378(1): 21-26.
|
| [19] |
Ho CC, Kuo SH, Huang PH, et al. Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. Lung cancer, 2008, 59(1): 105-110.
|
| [20] |
Satoh T, Yang G, Egawa S, et al. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients. Cancer, 2003, 97(5): 1225-1233.
|
| [21] |
Tang Y, Zeng X, He F, et al. Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. Medical oncology, 2012, 29(2): 977-984.
|